期刊
BIOMOLECULES
卷 12, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/biom12030433
关键词
multiple sclerosis; microbiome; gut-brain axis; disease-modifying drugs
资金
- Ministry of Health of the Czech Republic [NU20-04-00077]
- Institutional Research Concept RVO [MH CZ-DRO-VFN64165]
This article discusses the relationship between gut microbiota and the pathophysiology of multiple sclerosis (MS), emphasizing the importance of further research and understanding of the role of microbiota in MS treatment.
The composition of microbiota and the gut-brain axis is increasingly considered a factor in the development of various pathological conditions. The etiology of multiple sclerosis (MS), a chronic autoimmune disease affecting the CNS, is complex and interactions within the gut-brain axis may be relevant in the development and the course of MS. In this article, we focus on the relationship between gut microbiota and the pathophysiology of MS. We review the contribution of germ-free mouse studies to our understanding of MS pathology and its implications for treatment strategies to modulate the microbiome in MS. This summary highlights the need for a better understanding of the role of the microbiota in patients' responses to disease-modifying drugs in MS and disease activity overall.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据